C 43 H 34 NO 8 PS 2 Re 2 , monoclinic, P21/c (no. 14), a = 12.165 (8) 
Atom Site . Pyridine did not form part of the synthetic or crystallization procedure of the title compound but we suspect the pyridine in the reported structure came from a neighbouring solution where pyridine was used for the recrystallization of another complex.
Experimental details
The methoxy and aromatic H atoms were placed in geometrically idealized positions and constrained to ride on their parent atoms, with C-H = 0.93 and 0.96 Å and U iso (H) = 1.5Ueq(C) and 1.2Ueq(C), respectively. The highest peak (1.62 e Å −3 ) is located 0.86 Å from Re1 and the deepest hole (−1.22 e Å −3 ) is situated 0.75 Å from Re1.
Discussion
The title compound, Re 2 C 43 H 34 NO 8 PS 2 is synthesized from the Re(I)-tricarbonyl precursor which is currently under investigation in radiopharmaceutical research [1, 2] . The organometallic fragment fac-[M(CO) 3 ] + (M = Tc/Re) is used as a versatile synthon for the conjugation of biomolecules with technetium or rhenium [3] [4] [5] [6] [7] . One of the major advantages in using the fac-[M(CO) 3 ] + (M = Tc/Re) core is its high stability and e cient preparation in aqueous media. It also has the potential of exchanging speci cally the labile solvent ligands (i.e. water) to allow for the coordination of multidentate ligand systems [8, 9] . This contribution forms part of a longterm study to investigate di erent aspects of middle and late transition metal centers when coordinated to O, N and S donor ligands [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . The dinuclear structure (Figure) crystallized with one crystallographically independent molecule in the asymmetric unit. The dinuclear molecule has a Re 2 (µ-S) 2 
